LCTG-001 on course to be the first FDA-approved biologic from human milk for pediatric patients with Common Variable Immunodeficiency.
Through the SOPHIE program, PreOperative Performance will enter a 12-month co-development partnership with The Research Institute of St. Joe’s Hamilton
This press release was originally published by OBIO on April 11, 2023. Read the original post here. (Windsor, ON) –
A trained opera singer with an accomplished business background and a professor of chemistry, renowned globally for his research and
Innovation Factory Client, Rapid Dose Therapeutics is a Canadian life sciences company which provides disruptive proprietary drug delivery technologies designed to
EMN, a Canadian medical nutrition company, has raised a $1.2 Million seed round led by several prominent angel investors from
LCTG-001 on course to be the first FDA-approved biologic from human milk for pediatric patients with Common Variable Immunodeficiency.
Through the SOPHIE program, PreOperative Performance will enter a 12-month co-development partnership with The Research Institute of St. Joe’s Hamilton
This press release was originally published by OBIO on April 11, 2023. Read the original post here. (Windsor, ON) –
A trained opera singer with an accomplished business background and a professor of chemistry, renowned globally for his research and
Innovation Factory Client, Rapid Dose Therapeutics is a Canadian life sciences company which provides disruptive proprietary drug delivery technologies designed to
EMN, a Canadian medical nutrition company, has raised a $1.2 Million seed round led by several prominent angel investors from
Get the latest updates delivered straight to your inbox! Stay notified about companies on the grow, the latest tech trends, funding news and opportunities, industry insights, upcoming events and more from across Hamilton’s innovation ecosystem.
